Evidence map›Paper›PMID 37495770›Full record

SynthesisCell stress & chaperones2023

Extra and intra cellular HSP70 levels in adults with and without metabolic disorders: a systematic review and meta-analysis.

Carlos Henrique de Lemos Muller, Helena Trevisan Schroeder, Josianne Rodrigues-Krause, Maurício Krause

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cell stress & chaperones, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Carlos Henrique de Lemos MullerLaboratório de Pesquisa em Inflamação, Metabolismo e Exercício (LAPIMEX) E Laboratório de Fisiologia Celular, Departamento de Fisiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil.
Helena Trevisan SchroederLaboratório de Pesquisa em Inflamação, Metabolismo e Exercício (LAPIMEX) E Laboratório de Fisiologia Celular, Departamento de Fisiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil.
Josianne Rodrigues-KrausePrograma de Pós-Graduação Em Ciências Do Movimento Humano, Escola de Educação Física, Fisioterapia E Dança (ESEFID), Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90690-200, Brazil.
Maurício KrauseLaboratório de Pesquisa em Inflamação, Metabolismo e Exercício (LAPIMEX) E Laboratório de Fisiologia Celular, Departamento de Fisiologia, Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, RS, 90035-003, Brazil. mauricio.krause@ufrgs.br.ORCID 0000-0001-9814-742X
Universidade Federal do Rio Grande do Sul · BR

Funding

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 30791.434.41354.23112017 - CHAMADA FAPERGS/Decit/SCTIE/ MS/CNPq/SESRS n. 03/2017
6 · The paper itself

Abstract

Metabolic disorders, such as obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome (MS) are related to chronic pro-inflammatory conditions. Evidence suggests that heat shock proteins are linked to metabolic disorders. Intracellular HSP70 (iHSP70) is mandatory for normal insulin signalling, and proteostasis, and exerts a powerful anti-inflammatory role. On the other hand, the extracellular (eHSP72) is linked with a pro-inflammatory state and induces insulin resistance in humans. Then, we conducted a systematic review with meta-analysis to summarize the data of HSP70 in people with and without metabolic disorders. PubMed, Embase, Scopus, and Web of Science databases were used. Eligibility criteria included observational and baseline data of experimental studies that assessed iHSP70 and/or eHSP72 in adults with metabolic disorders and healthy people. The risk of bias was assessed by the Newcastle-Ottawa scale. Meta-analysis was performed using a random-effect model and the mean difference was estimated for eHSP72 and the standardized mean difference for iHSP70. A total of 11,255 articles were retrieved, 31 articles were assessed for eligibility and 15 were included for data extraction. There was no difference in eHSP72 between metabolic disorders and healthy controls (mean difference (MD) = 0.11; 95% confidence interval (CIs) = -0.05 to 0.27; I

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAdultHSP70 Heat-Shock ProteinsHumansInsulinObesityHSP70 Heat-Shock ProteinsInsulinHSP70Insulin resistanceMetabolic disordersMetabolic syndromeObesityType 2 diabetes mellitus

Identifiers

PMID37495770
PMCPMC10746644
OpenAlexW4385281133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.